Top Markets
Coin of the day
Oxurion N.V. Oxurion N.V.

Oxurion N.V.

OXUR
Ранг среди акций #39494
Headquartered in Leuven, Belgium, and established in 1991, Oxurion N.V. is a... Headquartered in Leuven, Belgium, and established in 1991, Oxurion N.V. is a biopharmaceutical firm focused on researching, developing, and bringing to market treatments for various ocular conditions worldwide. Its primary commercialized offering is JETREA, a medication used to address vitreomacular adhesion and vitreomacular traction. The company's development pipeline includes THR-149, a plasma kallikrein inhibitor currently undergoing Phase II clinical trials for diabetic macular edema (DME), and THR-687, an integrin antagonist also in Phase II trials for DME. Oxurion has forged strategic partnerships with Bicycle Therapeutics, INC Research, and Galapagos NV. The organization was formerly known as ThromboGenics NV before officially changing its name to Oxurion NV in September 2018.
Цена акции
$0.00332123
Рыночная капитализация
$467.41K
Изменение (1 день)
0.00%
Изменение (1 год)
-88.41%
Страна
BE
Торговля Oxurion N.V. (OXUR)

Категория

Коэффициент P/S для Oxurion N.V. (OXUR)
Коэффициент P/S на 2026 TTM: 0
Согласно последним финансовым отчетам и цене акций Oxurion N.V., текущий коэффициент P/S (TTM) составляет 0. В конце 2026 он составлял 0.
История P/S для Oxurion N.V. с 2026 по 2026
Коэффициент P/S в конце каждого года
Год P/S Изменить
Недостаточно данных для указанных дат.
Коэффициент P/S для аналогичных компаний или конкурентов
Компания P/S Разница P/S Страна
9.88 -
US
10.30 -
NL
- -
CH
- -
KR
4.98 -
BE